New approach evaluates effect of physical activity on estrogen metabolism in postmenopausal women

April 10, 2013

Researchers have generated new insights into the ways in which physical activity affects how much estrogen is broken down and secreted in the urine of postmenopausal women. These findings enhance understanding of the potential biological mechanisms linking increased physical activity and decreased risk for breast cancer in postmenopausal women, according to the scientist who presented the data at the AACR Annual Meeting 2013, held in Washington, D.C., April 6-10.

Previous studies have suggested that increased physical activity may reduce the risk for among postmenopausal women, and that this might be a result of physical activity lowering endogenous , according to Cher Dallal, Ph.D., a (NCI) fellow. However, few studies have evaluated the influence of physical activity on the breakdown of estrogens in postmenopausal women. This breakdown process, called estrogen metabolism, results in a variety of molecules known as metabolites.

"This is the first study to consider the relationship between -measured activity and a panel of estrogen metabolites measured in urine," said Dallal. "We hoped by using direct measures to examine this relationship that we could improve our knowledge of how these factors may influence cancer risk among postmenopausal women."

Dallal and colleagues studied 540 healthy, postmenopausal women who were enrolled in the NCI Polish Breast Cancer Study, conducted from 2000 to 2003. None of the women were taking menopausal hormone therapy. The investigators measured physical activity by accelerometer, which is a small device that women wore on their waists during waking hours for seven days. According to Dallal, accelerometers provide objective readings of physical activity compared with participants' self-reports, which have been the predominant measure in previous studies.

Women also provided a 12-hour urine sample. The researchers tested the samples for estradiol and estrone, two "parent" estrogens, plus 13 different estrogen metabolites using a new assay developed by the NCI. According to Dallal, this novel assay can detect multiple urinary estrogens, compared with those used in previous studies that only measured one or two metabolites individually.

The researchers found that increased physical activity was associated with lower levels of parent estrogens. In addition, higher levels of physical activity were associated with lower levels of four specific estrogen metabolites. Dallal cautions, however, that further research on estrogen metabolism will be needed to understand how these metabolites play a role in mediating breast .

"By using these new tools to study the relationship between activity and estrogen metabolism, we hope to get closer to uncovering the combination of parent estrogens, metabolites and metabolism pathways that are related to a lower-risk profile of breast cancer," said Dallal.

Explore further: Menopausal hormone therapy and breast cancer risk

Related Stories

Menopausal hormone therapy and breast cancer risk

March 15, 2012
In the past decade, results from large prospective cohort studies and the Women's Health Initiative (WHI) randomized placebo-controlled hormone therapy trials have substantially changed thoughts about how estrogen alone and ...

Elevated hormone levels add up to increased breast cancer risk

October 21, 2011
Post-menopausal women with high levels of hormones such as estrogen or testosterone are known to have a higher risk of breast cancer. New research published in BioMed Central's open access journal Breast Cancer Research looked ...

Recommended for you

Study provides insight into link between two rare tumor syndromes

August 22, 2017
UCLA researchers have discovered that timing is everything when it comes to preventing a specific gene mutation in mice from developing rare and fast-growing cancerous tumors, which also affects young children. This mutation ...

Retaining one normal BRCA gene in breast, ovarian cancers influences patient survival

August 22, 2017
Determining which cancer patients are likely to be resistant to initial treatment is a major research effort of oncologists and laboratory scientists. Now, ascertaining who might fall into that category may become a little ...

Study identifies miR122 target sites in liver cancer and links a gene to patient survival

August 22, 2017
A new study of a molecule that regulates liver-cell metabolism and suppresses liver-cancer development shows that the molecule interacts with thousands of genes in liver cells, and that when levels of the molecule go down, ...

Zebrafish larvae could be used as 'avatars' to optimize personalized treatment of cancer

August 21, 2017
Portuguese scientists have for the first time shown that the larvae of a tiny fish could one day become the preferred model for predicting, in advance, the response of human malignant tumors to the various therapeutic drugs ...

Scientists discover vitamin C regulates stem cell function, curbs leukemia development

August 21, 2017
Not much is known about stem cell metabolism, but a new study from the Children's Medical Center Research Institute at UT Southwestern (CRI) has found that stem cells take up unusually high levels of vitamin C, which then ...

Searching for the 'signature' causes of BRCAness in breast cancer

August 21, 2017
Breast cancer cells with defects in the DNA damage repair-genes BRCA1 and BRCA2 have a mutational signature (a pattern of base swaps—e.g., Ts for Gs, Cs for As—throughout a genome) known in cancer genomics as "Signature ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.